Low 2018/19 vaccine effectiveness against influenza A(H3N2) among 15–64-year-olds in Europe: exploration by birth cohortEsther Kissling, Francisco Pozo, Silke Buda et al.|Eurosurveillance|2019Cited by 48
Influenza vaccine effectiveness against influenza A subtypes in Europe: Results from the 2021–2022 I‐MOVE primary care multicentre studyEsther Kissling, Neus Latorre‐Margalef, Sanja Filipović et al.|Influenza and Other Respiratory Viruses|2022Cited by 45
Effectiveness of influenza vaccine against influenza A in Europe in seasons of different A(H1N1)pdm09 and the same A(H3N2) vaccine components (2016–17 and 2017–18)Esther Kissling, Marta Valenciano, Francisco Pozo et al.|Vaccine X|2019Cited by 36
Exploring the effect of previous inactivated influenza vaccination on seasonal influenza vaccine effectiveness against medically attended influenza: Results of the European I‐<scp>MOVE</scp> multicentre test‐negative case‐control study, 2011/2012‐2016/2017Marta Valenciano, Alain Moren, Esther Kissling et al.|Influenza and Other Respiratory Viruses|2018Cited by 36
Influenza vaccine effectiveness against influenza A subtypes in Europe: results from the 2021–22 I-MOVE primary care multicentre studyEsther Kissling, Marta Valenciano, Francisco Pozo et al.|Unknown|2022Cited by 1